Related content

Long-term cost-effectiveness of clopidogrel in patients with acute coronary syndrome without ST-segment elevation in Germany

By Brüggenjürgen B.   Lindgren P.   Ehlken B.   Rupprecht H.-J.   Willich S.  

The European Journal of Health Economics, Vol. 8, Iss. 1, 2007-03 ,pp. : 51-57

Springer Publishing Company

Access to resources Recommend Favorite

A third troponin T blood sample is not cost-effective in patients with suspected non-ST segment elevation acute coronary syndrome

By Alzuhairi Karam S. M.   Hjortshøøj Søøren   Kristensen Søøren Risom   Ravkilde Jan  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 71, Iss. 2, 2011-04 ,pp. : 117-122

Informa Healthcare

Access to resources Recommend Favorite

Comparison between Second and Third Generation Troponin T Assay in Patients with Symptoms Suggestive of an Acute Coronary Syndrome but without ST Segment Elevation

By  

Cardiology, Vol. 100, Iss. 1, 2003-09 ,pp. : 29-35

Karger

Access to resources Recommend Favorite

Trastuzumab-Induced Myocardiotoxicity Mimicking Acute Coronary Syndrome

By  

Case Reports in Oncology, Vol. 5, Iss. 1, 2012-03 ,pp. : 125-133

Karger

Access to resources Recommend Favorite

Baseline White Blood Cell Count Is an Independent Predictor of Long-Term Cardiovascular Mortality in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome, but It Does Not Improve the Risk Classification of the GRACE Score

By  

Cardiology, Vol. 124, Iss. 2, 2013-02 ,pp. : 97-104

Karger

Access to resources Recommend Favorite